N. Devoogdt, PT, PhD, Department of Rehabilitation Sciences, KU Leuven-University of Leuven, Tervuursevest 101, Leuven, Belgium, and Leuven Lymphoedema Center, University Hospitals Leuven, Leuven, Belgium.
Phys Ther. 2014 May;94(5):705-21. doi: 10.2522/ptj.20130285. Epub 2014 Jan 10.
Patients may develop primary (congenital) or secondary (acquired) lymphedema, causing significant physical and psychosocial problems. To plan treatment for lymphedema and monitor a patient's progress, swelling, and problems in functioning associated with lymphedema development should be assessed at baseline and follow-up.
The purpose of this study was to investigate the reliability (test-retest, internal consistency, and measurement variability) and validity (content and construct) of data obtained with the Lymphoedema Functioning, Disability and Health Questionnaire for Lower Limb Lymphoedema (Lymph-ICF-LL).
This was a multicenter, cross-sectional study.
The Lymph-ICF-LL is a descriptive, evaluative tool containing 28 questions about impairments in function, activity limitations, and participation restrictions in patients with lower limb lymphedema. The questionnaire has 5 domains: physical function, mental function, general tasks/household activities, mobility activities, and life domains/social life. The reliability and validity of the Lymph-ICF-LL were examined in 30 participants with objective lower limb lymphedema.
Intraclass correlation coefficients for test-retest reliability ranged from .69 to .94, and Cronbach alpha coefficients for internal consistency ranged from .82 to .97. Measurement variability was acceptable (standard error of measurement=5.9-12.6). Content validity was good because all questions were understandable for 93% of participants, the scoring system (visual analog scale) was clear, and the questionnaire was comprehensive for 90% of participants. Construct validity was good. All hypotheses for assessing convergent validity and divergent validity were accepted.
The known-groups validity and responsiveness of the Dutch Lymph-ICF-LL and the cross-cultural validity of the English version of the Lymph-ICF-LL were not investigated.
The Lymph-ICF-LL is a Dutch questionnaire with evidence of reliability and validity for assessing impairments in function, activity limitations, and participation restrictions in people with primary or secondary lower limb lymphedema.
患者可能会出现原发性(先天性)或继发性(获得性)淋巴水肿,导致明显的身体和心理社会问题。为了规划淋巴水肿的治疗并监测患者的进展,应在基线和随访时评估肿胀以及与淋巴水肿发展相关的功能障碍。
本研究旨在调查下肢淋巴水肿功能、残疾和健康问卷(Lymph-ICF-LL)的可靠性(测试-重测、内部一致性和测量变异性)和有效性(内容和结构)。
这是一项多中心、横断面研究。
Lymph-ICF-LL 是一种描述性、评估性工具,包含 28 个关于下肢淋巴水肿患者功能障碍、活动受限和参与受限的问题。问卷有 5 个领域:身体功能、心理功能、一般任务/家务活动、移动活动和生活领域/社会生活。在 30 名患有下肢淋巴水肿的客观患者中,检查了 Lymph-ICF-LL 的可靠性和有效性。
测试-重测的组内相关系数范围为.69 至.94,内部一致性的 Cronbach alpha 系数范围为.82 至.97。测量变异性可接受(测量误差=5.9-12.6)。内容效度良好,因为 93%的参与者都能理解所有问题,评分系统(视觉模拟量表)清晰,90%的参与者认为问卷全面。结构效度良好。评估收敛有效性和发散有效性的所有假设均被接受。
未研究荷兰版 Lymph-ICF-LL 的已知组有效性和反应性以及英文版 Lymph-ICF-LL 的跨文化有效性。
Lymph-ICF-LL 是一种荷兰语问卷,具有评估原发性或继发性下肢淋巴水肿患者功能障碍、活动受限和参与受限的可靠性和有效性的证据。